Tenaya Therapeutics Q2 Net Income USD -43.393 Million
TNYA•Second-quarter financial results
Aug. 5 (Reuters) - Tenaya Therapeutics Q2 basic EPS was USD -0.2.
- Q2 operating expenses were USD 45.198 million
- Q2 pretax profit was USD -43.393 million
- Q2 operating income was USD -44.088 million




